ArticleStem cell research & therapy2023

Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway.

Xiaoxuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.